Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Prostatic Neoplasms 2Small Cell Lung Carcinoma 1Rectal Neoplasms 1Radiation-induced Injuries in Patients With Rectal Cancer 1Radiation Injuries 1Precancerous Conditions 1Neoplasms, Second Primary 1Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Fibrosis 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Adenomatous Polyps 1

Interventions

Radiotherapy 8Cisplatin 3Carboplatin 3sargramostim 2Radiotherapy, Intensity-Modulated 2Paclitaxel 2Donepezil 2cevimeline 1beta Carotene 1alpha-Tocopherol 1Zinc Sulfate 1Vortioxetine 1Vitamin E 1Standard of Care 1Sodium Chloride 1Salts 1Radiotherapy, Conformal 1Radiosurgery 1Oxygen 1Oxaliplatin 1Neck Dissection 1Mometasone Furoate 1Meditation 1Hyperbaric Oxygenation 1Glutamine 1G(M1) Ganglioside 1Filgrastim 1Fibroblast Growth Factor 7 1Etoposide 1Erythropoietin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Radiation Injuries × alpha-Tocopherol × Clear all
NCT00169845 2018-03-14

Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients

Laval University

Phase 3 Completed
540 enrolled
Head & Neck

Head and Neck Neoplasms, Neoplasms, Radiation Injuries, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡